Managing a modern clinical trial can feel a bit like herding cats. Every vendor brings specialized expertise, but each also has its own processes, priorities, timelines, and communication styles. At the same time, central labs, imaging vendors, pharmacovigilance providers, ePRO platforms, recruitment specialists, and CROs all play important roles in moving studies forward.

The challenge is that each of these vendors operates within its own systems and processes, and as studies become more complex, so does the number of moving parts. A delay in one area can quickly affect several others, leading to bottlenecks that affect outcomes. For sponsors to successfully navigate this new environment, coordination between vendors is key. 

When more vendors create more complexity

Specialization has brought many benefits to clinical research. Sponsors can engage subject matter experts for nearly every aspect of trial execution, improving quality and providing access to capabilities that may not exist internally. But every additional vendor introduces new communication pathways and dependencies.

Consider this common scenario: A central lab identifies a discrepancy in sample collection data. Contacting one vendor to address the issue wouldn’t be that big of a deal, but nowadays it often involves coordination between the site, CRO, sponsor, and potentially a data management team. If ownership isn’t clear or communication breaks down, a relatively minor issue can remain unresolved for days or weeks.

Situations like these are rarely the result of poor performance from a single vendor. More often, they occur because information isn’t flowing efficiently between organizations. As vendor ecosystems grow, sponsors need a strategy for keeping all participants aligned. That process starts by clarifying who’s responsible for what.

Establish clear ownership from day one

One of the fastest ways for a study to lose momentum is when team members aren’t sure who owns particular decisions or activities. This can happen during study startup, but it can also happen later as protocols evolve or new vendors join the project. 

Sponsors can reduce confusion by defining ownership early and documenting it clearly. This includes:

•  Operational responsibilities
• Decision-making authority
• Escalation pathways.

For example, if your team identifies a data discrepancy, everyone involved needs to understand who:

• Investigates the issue
• Approves corrective actions
• Communicates updates to stakeholders. 

The same principle applies to protocol deviations, site concerns, and countless other operational challenges.

Clear ownership creates accountability and helps teams move faster because they spend less time determining who should act and instead solving the problem. Of course, ownership alone isn’t enough. Teams also need a reliable way to share information and stay aligned.

Create a shared communication framework

Working from disparate or siloed information sources can trip up even the most experienced vendors. Sponsors often assume communication will happen naturally once a study begins, but  communication requires structure. Without it, updates become inconsistent, action items may fall through the cracks, and small issues can grow into larger operational risks.

A shared communication framework helps keep everyone on the same page. The exact approach will vary by study, but most successful programs use a framework that involves:

•  Consistent governance meetings
• Shared action logs
• Standardized reporting expectations
• Clearly defined communication channels 

Together, these factors can create more visibility and help teams identify potential issues before they affect timelines or quality.

Just as important, a communication framework establishes a common understanding of priorities. When vendors understand how their work affects other stakeholders, collaboration becomes easier.

Maintaining alignment is a major step forward, but communication is only one aspect of vendor coordination. Sponsors also need a way to evaluate whether their ecosystem is functioning as intended.

Monitor performance across the entire trial ecosystem

Vendor performance reviews typically focus on individual metrics. These metrics are important, but they don’t always provide a complete picture of where a study stands or its overall health.

A vendor may be meeting its contractual obligations while larger operational issues continue to impact study progress. For that reason, sponsors should evaluate not only how vendors perform independently, but also how effectively they work together.

Cross-functional metrics can be particularly valuable. Examples include turnaround times for issue resolution, the number of recurring data reconciliation challenges, response times for escalations, or delays associated with vendor handoffs.

If you review these metrics regularly, it’s easier to spot patterns. For instance, a sponsor may discover that multiple teams are encountering the same bottleneck, even though everything looks fine on paper. Looking at the trial ecosystem as a whole provides a more accurate view of operational effectiveness and makes it easier to continuously improve.

Build escalation paths before problems occur

Every clinical trial runs into unexpected challenges or hiccups. A critical data issue may arise or a vendor might miss a crucial milestone. You can’t always predict these situations, but if you’ve planned ahead, you can handle them more effectively. 

Establishing escalation pathways is one of the most effective strategies, because they can help eliminate uncertainty during high-pressure situations.Every situation is different, but if something goes wrong, teams should know:

• Which issues require escalation
• Who should be notified
• How quickly they should take action

Documenting these expectations up front prevents confusion and reduces the likelihood that major concerns go unresolved. 

Strong escalation processes also help eliminate surprises. Stakeholders can make better decisions when they have access to all of the necessary information. This is especially important as studies progress and operational demands evolve.

Treat vendor coordination as an ongoing activity

It’s easy to assume that establishing a vendor coordination plan is a one-time startup exercise. However, clinical trials are dynamic. Enrollment trends often change and vendors may expand their responsibilities or transition personnel. As a study moves forward, even small changes can become larger operational challenges.

For that reason, sponsors should regularly reassess how their vendors work together. Governance plans, communication processes, performance metrics, and escalation procedures should be reviewed regularly to ensure they still meet the study’s needs.

The most successful sponsor teams know that vendor coordination requires ongoing attention. By checking in regularly and making adjustments when needed, they can keep vendors aligned and move the study forward. 

When coordination becomes a competitive advantage

As clinical research becomes more complex and spread across multiple sites, the need for specialized vendors will only increase. The good news is that sponsors don’t need to choose between expertise and operational control. 

By establishing clear ownership, creating structured communication pathways, monitoring performance across the broader ecosystem, and defining escalation processes early, organizations can keep vendors coordinated and on the same page.

At Harbor Clinical, we help sponsors navigate these challenges through flexible support models tailored to their operational needs. Whether you’re building a vendor oversight strategy, strengthening governance processes, or looking for additional clinical operations expertise, our team can help you maintain visibility and keep your studies moving forward.

Learn more about our capabilities by requesting a proposal.